Evoke Pharma

Yahoo Finance • 2 days ago

Trending tickers: ASML, Pop Mart International, Evoke, Boohoo and Halfords

ASML (ASML.AS) With Wall Street closed for Thanksgiving on Thursday, the focus turned to stocks in other markets, including Dutch chip equipment maker ASML (ASML.AS). ASML (ASML.AS) was trending after Morgan Stanley named the company as... Full story

Yahoo Finance • 15 days ago

Halper Sadeh LLC Encourages JAMF, CIVI, EVOK Shareholders to Contact the Firm to Discuss Their Rights

NEW YORK, Nov. 14, 2025 (GLOBE NEWSWIRE) -- Halper Sadeh LLC, an investor rights law firm, is investigating the following companies for potential violations of the federal securities laws and/or breaches of fiduciary duties to shareholde... Full story

Yahoo Finance • 23 days ago

Halper Sadeh LLC Encourages DENN, EVOK, ODP Shareholders to Contact the Firm to Discuss Their Rights

NEW YORK, Nov. 06, 2025 (GLOBE NEWSWIRE) -- Halper Sadeh LLC, an investor rights law firm, is investigating the following companies for potential violations of the federal securities laws and/or breaches of fiduciary duties to shareholde... Full story

Yahoo Finance • 24 days ago

BRODSKY & SMITH SHAREHOLDER UPDATE: Notifying Investors of the Following Investigations: Kenvue Inc. (NYSE - KVUE), Sonida Senior Living, Inc. (NYSE - SNDA), Evoke Pharma Inc. (Nasdaq - EVOK), SM Energy Company (NYSE - SM)

BALA CYNWYD, Pa., Nov. 05, 2025 (GLOBE NEWSWIRE) -- Brodsky & Smith reminds investors of the following investigations. If you own shares and wish to discuss the investigation, contact Jason Brodsky (jbrodsky@brodskysmith.com) or Marc Ack... Full story

Yahoo Finance • 25 days ago

$HAREHOLDER ALERT: The M&A Class Action Firm Announces An Investigation of Evoke Pharma, Inc. (NASDAQ: EVOK)

NEW YORK, Nov. 04, 2025 (GLOBE NEWSWIRE) -- Class Action Attorney Juan Monteverde with Monteverde & Associates PC (the “M&A Class Action Firm”), has recovered millions of dollars for shareholders and is recognized as a Top 50 Firm in the... Full story

Yahoo Finance • 3 months ago

Evoke Pharma and EVERSANA Expand GIMOTI® Access to Gastro Health and Other Large GI Practices through Omnicell Relationship

Separately Secures Access to OneGI Through Brentwood Pharmacy Agreement Gimoti Specialty Pharmacy Network to Almost Double with Additional Relationships SOLANA BEACH, Calif. and CHICAGO, Aug. 26, 2025 (GLOBE NEWSWIRE) -- Evoke Pharma,... Full story

Yahoo Finance • 3 months ago

Wondering what's happening in today's pre-market session?

Wondering what's happening in Friday's pre-market session? Find an overview in this article. [premarket] PRE-MARKET GAINERS TICKER CHANGE COMMENT EEIQ [https://www.chartmill.com/stock/quote/EEIQ/profile] 127.0% EPICQUEST... Full story

Yahoo Finance • 3 months ago

Thursday's after hours session: top gainers and losers

The US market regular session of Thursday is over, let's have a look at the top gainers and losers in the after hours session today. [postmarket] GAINERS TICKER CHANGE COMMENT MODV [https://www.chartmill.com/stock/quote/MODV/... Full story

Yahoo Finance • 3 months ago

These stocks that are showing activity before the opening bell on Thursday.

As we await the opening of the US market on Thursday, let's delve into the pre-market session and discover the top gainers and losers shaping the early market sentiment. [premarket] PRE-MARKET GAINERS TICKER CHANGE COMMENT AP... Full story

Yahoo Finance • 3 months ago

Evoke Pharma Announces Listing of New GIMOTI® Patent in FDA Orange Book

SOLANA BEACH, Calif., Aug. 21, 2025 (GLOBE NEWSWIRE) -- Evoke Pharma, Inc. (NASDAQ: EVOK), a specialty pharmaceutical company focused primarily on treatments for gastrointestinal (GI) diseases with an emphasis on GIMOTI® (metoclopramide)... Full story

Yahoo Finance • 4 months ago

Evoke Pharma Reports Second Quarter 2025 Financial Results and Provides Business Update

SOLANA BEACH, Calif., Aug. 14, 2025 (GLOBE NEWSWIRE) -- Evoke Pharma, Inc. (NASDAQ: EVOK), a specialty pharmaceutical company focused on treatments for gastrointestinal (GI) disorders with an emphasis on GIMOTI® (metoclopramide) nasal sp... Full story

Yahoo Finance • 4 months ago

Evoke reaffirms FY25 guidance, implies 3% profit beat on stronger margins

Investing.com -- Evoke (LON:EVOK) on Wednesday reaffirmed its fiscal 2025 revenue growth forecast of 5% to 9% and projected EBITDA margins of at least 20%, which at the lower end of guidance equates to about £368 million, roughly 3% above... Full story

Yahoo Finance • 4 months ago

evoke reports 3% revenue growth and 44% adjusted EBITDA increase in H1 2025

LONDON - evoke Plc (LSE:EVOK), one of the world’s leading betting and gaming companies, reported a 3% increase in revenue to £887.8 million and a 44% jump in Adjusted EBITDA to £165.9 million for the first half of 2025, marking its fourth... Full story

Yahoo Finance • 4 months ago

Evoke Pharma Announces Issuance of New U.S. Patent for GIMOTI With Extended Exclusivity to Late 2038

SOLANA BEACH, Calif., Aug. 06, 2025 (GLOBE NEWSWIRE) -- Evoke Pharma, Inc. (NASDAQ: EVOK), a specialty pharmaceutical company focused primarily on treatments for gastrointestinal (GI) diseases with an emphasis on GIMOTI® (metoclopramide)... Full story

Yahoo Finance • 5 months ago

U.S. stocks higher at close of trade; Dow Jones Industrial Average up 0.49%

Investing.com – U.S. stocks were higher after the close on Wednesday, as gains in the Technology, Utilities and Industrials sectors led shares higher. At the close in NYSE, the Dow Jones Industrial Average gained 0.49%, while the S&P 500... Full story

Yahoo Finance • 5 months ago

Evoke Pharma stock soars after receiving patent allowance for GIMOTI

Investing.com -- Evoke Pharma Inc (NASDAQ:EVOK) stock surged 50% after the specialty pharmaceutical company received a Notice of Allowance from the United States Patent and Trademark Office for a patent application covering its gastropares... Full story

Yahoo Finance • 5 months ago

Evoke Pharma receives patent allowance for gastroparesis nasal spray

SOLANA BEACH, Calif. - Evoke Pharma, Inc. (NASDAQ:EVOK), a specialty pharmaceutical company with a market capitalization of $5.38 million and impressive revenue growth of ~90% over the last twelve months, has received a Notice of Allowance... Full story

Yahoo Finance • 5 months ago

Evoke Pharma Receives Notice of Allowance for U.S. Patent Application for GIMOTI Extending Orange Book listings to 2036

SOLANA BEACH, Calif., July 09, 2025 (GLOBE NEWSWIRE) -- Evoke Pharma, Inc. (NASDAQ: EVOK), a specialty pharmaceutical company focused primarily on treatments for gastrointestinal (GI) diseases with an emphasis on GIMOTI® (metoclopramide)... Full story

Yahoo Finance • 5 months ago

evoke director Andrea Gisle Joosen to join Atlantic Grupa board

LONDON - Evoke plc announced Thursday that Andrea Gisle Joosen, Independent Non-Executive Director at the company, will be appointed as a member of the Supervisory Board of Atlantic Grupa d.d., effective September 4, 2025. The appointment... Full story

Yahoo Finance • 5 months ago

Andrea Gisle Joosen appointed to Grafton Group board

LONDON - Evoke PLC announced Wednesday that Andrea Gisle Joosen, an Independent Non-Executive Director at the company, has been appointed as Non-Executive Director of Grafton Group plc, effective July 1, 2025. According to the company sta... Full story